======= ACADS =======
== Gene Information ==
* **Official Symbol**: ACADS
* **Official Name**: acyl-CoA dehydrogenase short chain
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=35|35]]
* **UniProt**: [[https://www.uniprot.org/uniprot/P16219|P16219]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=ACADS&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ACADS|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/606885|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a tetrameric mitochondrial flavoprotein, which is a member of the acyl-CoA dehydrogenase family. This enzyme catalyzes the initial step of the mitochondrial fatty acid beta-oxidation pathway. Mutations in this gene have been associated with short-chain acyl-CoA dehydrogenase (SCAD) deficiency. Alternative splicing results in two variants which encode different isoforms. [provided by RefSeq, Oct 2014].
* **UniProt Summary**: Introduces a double bond at position 2 in saturated acyl-CoA's of short chain length, i.e. less than 6 carbon atoms. {ECO:0000250|UniProtKB:P15651}.
|Acyl-CoA dh 2|
|Acyl-CoA dh M|
|Acyl-CoA dh 1|
|Acyl-CoA dh N|
|butyryl-CoA dehydrogenase activity|
|butyrate catabolic process|
|butyrate metabolic process|
|acyl-CoA dehydrogenase activity|
|short-chain fatty acid catabolic process|
|fatty acid beta-oxidation using acyl-CoA dehydrogenase|
|short-chain fatty acid metabolic process|
|fatty acid beta-oxidation|
|flavin adenine dinucleotide binding|
|fatty acid oxidation|
|lipid oxidation|
|fatty acid catabolic process|
|monocarboxylic acid catabolic process|
|cellular lipid catabolic process|
|lipid modification|
|organic acid catabolic process|
|carboxylic acid catabolic process|
|lipid catabolic process|
|fatty acid metabolic process|
|mitochondrial matrix|
|small molecule catabolic process|
|monocarboxylic acid metabolic process|
|carboxylic acid metabolic process|
|cellular lipid metabolic process|
|oxidation-reduction process|
|oxoacid metabolic process|
|organic acid metabolic process|
|lipid metabolic process|
|mitochondrion|
|small molecule metabolic process|
|organic substance catabolic process|
|cellular catabolic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp410|THZ531 0.11 to 0.125μM on day4 R07 exp410]]|1.74|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 13086
* **Expression level (log2 read counts)**: 3.9
{{:chemogenomics:nalm6 dist.png?nolink |}}